Articles related to PEDIATRIC ALLERGIES

Combined omalizumab-OIT therapy demonstrated an impressive 50-percentage-point advantage over placebo in food challenge success rates for children with multiple food allergies.

A longitudinal study demonstrates that early peanut introduction can reduce allergy risk by 81%, with protection persisting through early adolescence despite varying consumption patterns.

Up to 17% of infants develop milk protein allergy, making it one of the most prevalent gastrointestinal disorders in the first year of life.

Recent findings suggest that a slow up-dosing strategy in peanut oral immunotherapy for young children may offer a safer and more effective approach to managing peanut allergies.